Work-based content
Competencies
| # | Learning outcome | Competency | Action |
|---|---|---|---|
| # 1 | Learning outcome 2,3,4,7 |
Competency
Generate or critically review the design of suitable equipment and facilities for patient therapies- |
Action View |
| # 2 | Learning outcome 1,2 |
Competency
Advise on the appropriateness of requests for the administration of radionuclide therapy |
Action View |
| # 3 | Learning outcome 1,2,3 |
Competency
Prepare or critically review a radiation risk assessment for the administration of a particular form of radionuclide therapy |
Action View |
| # 4 | Learning outcome 2,3,5 |
Competency
Write or critically review standard operating procedures for the administration of particular form(s) of radionuclide therapy, incorporating the results of the risk assessment |
Action View |
| # 5 | Learning outcome 2,3 |
Competency
Perform a tailored radiation risk assessment and instructions for those in contact with an individual radionuclide therapy outpatient |
Action View |
| # 6 | Learning outcome 2,3,4,5,7 |
Competency
Prepare or review written instructions for staff on the management of inpatients receiving a particular radionuclide therapy, and give advice to staff in accordance |
Action View |
| # 7 | Learning outcome 2,6 |
Competency
Actively contribute to the administration of a range of radionuclide therapies, including at least iodine-131 for thyroid cancer and benign thyroid disease |
Action View |
| # 8 | Learning outcome 2,6 |
Competency
Assist and advise medical practitioners in the administration of non-oral radionuclide therapies, eg by intravenous infusion |
Action View |
| # 9 | Learning outcome 3 |
Competency
Advise patients and their carers on appropriate post-therapy behavioural restrictions |
Action View |
| # 10 | Learning outcome 7 |
Competency
Actively participate in the monitoring of inpatients to determine effective half-life and/or residual activity and managing the criteria for release of inpatients based on the results of this monitoring |
Action View |
| # 11 | Learning outcome 6 |
Competency
Perform contamination monitoring and decontamination of a treatment room post radionuclide therapy administration |
Action View |
| # 12 | Learning outcome 6 |
Competency
Record, store and dispose of radioactive waste produced as a result of radionuclide therapy |
Action View |
| # 13 | Learning outcome 1-8 |
Competency
Participate in clinical audit of radionuclide therapy |
Action View |
| # 14 | Learning outcome 7,8 |
Competency
Actively participate in acquisition of imaging data and/or data from radiation detectors/monitors |
Action View |
| # 15 | Learning outcome 8 |
Competency
Actively participate in calculating absorbed radiation doses to target and non-target tissues for therapy protocols guided by patient-specific dosimetry |
Action View |
Assessments
You must complete:
- 1 case-based discussion(s)
- 1 of the following DOPS/ OCEs:
| Monitor a patient in the therapy room | DOPS |
| Administer a therapy for benign thyroid disease, under supervision | DOPS |
| Set up under supervision a therapy infusion | DOPS |
| Decontaminate a therapy room once the patient has left | DOPS |
| Analyse the monitoring data to calculate the activity remaining in a therapy patient when they leave hospital. | DOPS |
| Prepare instructions for a therapy patient on leaving hospital. | DOPS |
| Calculate the total activity administered to a patient by calculating activity of waste. Record results and store waste appropriately. | DOPS |
| Perform a tailored risk assessment for a patient undergoing out-patient therapy. | DOPS |
| Explain details of a therapy administration to a patient | OCE |
| Explain precautions to a patient who has had Radioiodine therapy for benign thyroid disease | OCE |
| Explain precautions to a patient who has had Radioiodine therapy for thyroid cancer. | OCE |
| Explain monitoring procedure to a therapy patient | OCE |
| Give a presentation about the shielding requirements of different types of radionuclide therapy. | OCE |
Learning outcomes
- Advise on the choice of radiopharmaceutical for radionuclide therapy in terms of the physical properties of the radionuclide, the physiological properties of the radiopharmaceutical and the clinical context of the procedure
- Advise on and perform practical aspects of the administration of radionuclide therapy to patients
- Specify, and explain to the patient, the post-therapy behavioural restrictions placed on them
- Specify the facilities required for radionuclide therapy
- Implement and advise on the principles of management of radiation safety associated with radionuclide therapy administrations and patients
- Undertake practical radiation safety tasks required to deliver a service, including the effective communication of risk, decontamination procedures and radioactive waste management
- Specify and perform the radiation monitoring of inpatients to determine their point of release
- Implement the principles of internal radiation dosimetry, patient-specific dosimetry protocols and their requirements for data acquisition and analysis